1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one

C91H101Br2Cl3N20O13 — CID 162132979

IUPAC1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one
SMILESCOc1ccc(CCC(=O)NCCCl)cc1.COc1ccc(CN)cc1.COc1ccc(CN2CCN(c3ccnc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3ccnc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCNC2=O)cc1
InChIInChI=1S/2C15H15BrN4O2.2C15H15ClN4O2.C12H16ClNO2.C11H14N2O2.C8H11NO/c1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-16-11-5-2-10(3-6-11)4-7-12(15)14-9-8-13;1-15-10-4-2-9(3-5-10)8-13-7-6-12-11(13)14;1-10-8-4-2-7(6-9)3-5-8/h4*2-7H,8-10H2,1H3;2-3,5-6H,4,7-9H2,1H3,(H,14,15);2-5H,6-8H2,1H3,(H,12,14);2-5H,6,9H2,1H3
InChIKeyZIXFZVLBDGVJDJ-UHFFFAOYSA-N
MW1949.10 g/mol
LogP14.90
Rot. Bonds27

About 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one

1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one (PubChem CID 162132979) has the molecular formula C91H101Br2Cl3N20O13 and a molecular weight of 1949.10 g/mol. Its IUPAC name is 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one.

Molecular Properties

Compound Name1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one
PubChem CID162132979
Molecular FormulaC91H101Br2Cl3N20O13
Molecular Weight1949.10 g/mol
Exact Mass1944.53
IUPAC Name1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one
SMILESCOc1ccc(CCC(=O)NCCCl)cc1.COc1ccc(CN)cc1.COc1ccc(CN2CCN(c3ccnc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3ccnc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCNC2=O)cc1
InChIInChI=1S/2C15H15BrN4O2.2C15H15ClN4O2.C12H16ClNO2.C11H14N2O2.C8H11NO/c1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-16-11-5-2-10(3-6-11)4-7-12(15)14-9-8-13;1-15-10-4-2-9(3-5-10)8-13-7-6-12-11(13)14;1-10-8-4-2-7(6-9)3-5-8/h4*2-7H,8-10H2,1H3;2-3,5-6H,4,7-9H2,1H3,(H,14,15);2-5H,6-8H2,1H3,(H,12,14);2-5H,6,9H2,1H3
InChIKeyZIXFZVLBDGVJDJ-UHFFFAOYSA-N
XLogP14.90
TPSA349.39 Ų
H-Bond Donors3
H-Bond Acceptors22
Rotatable Bonds27
Heavy Atoms129
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001949.10
LogP ≤ 514.90
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-amino-9-[(4-methoxyphenyl)methyl]-7-prop-2-ynylpurin-8-one;2-amino-7-[(4-methoxyphenyl)methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-amino-7-prop-2-ynyl-9H-purin-8-one;3-bromoprop-1-yne;6-chloro-4-N-[(4-methoxyphenyl)methyl]pyrimidine-2,4,5-triamine;4-N-[(4-methoxyphenyl)methyl]pyrimidine-2,4,5-triamine;N-(8-oxo-7-prop-2-ynyl-9H-purin-2-yl)acetamide
CID 158495696
Bis(1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one);1-(2-chloroethyl)-3-[(4-methoxyphenyl)methyl]urea;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one
CID 160691296
1-(2-Bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(2-chloroethyl)-3-[(4-methoxyphenyl)methyl]urea;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one
CID 161024047

Frequently Asked Questions

What is the IUPAC name of 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one?
The IUPAC name of 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one (CID 162132979) is 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one.
What is the SMILES notation for 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one?
The canonical SMILES for 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one is COc1ccc(CCC(=O)NCCCl)cc1.COc1ccc(CN)cc1.COc1ccc(CN2CCN(c3ccnc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3ccnc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Br)n3)C2=O)cc1.COc1ccc(CN2CCN(c3nccc(Cl)n3)C2=O)cc1.COc1ccc(CN2CCNC2=O)cc1.
What is the InChIKey of 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one?
The InChIKey is ZIXFZVLBDGVJDJ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C15H15BrN4O2.2C15H15ClN4O2.C12H16ClNO2.C11H14N2O2.C8H11NO/c1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)13-6-7-17-14(16)18-13;1-22-12-4-2-11(3-5-12)10-19-8-9-20(15(19)21)14-17-7-6-13(16)18-14;1-16-11-5-2-10(3-6-11)4-7-12(15)14-9-8-13;1-15-10-4-2-9(3-5-10)8-13-7-6-12-11(13)14;1-10-8-4-2-7(6-9)3-5-8/h4*2-7H,8-10H2,1H3;2-3,5-6H,4,7-9H2,1H3,(H,14,15);2-5H,6-8H2,1H3,(H,12,14);2-5H,6,9H2,1H3.
What are the key properties of 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one?
1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one has a molecular weight of 1949.10 g/mol, XLogP of 14.90, 27 rotatable bonds, 3 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2-bromopyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-bromopyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;N-(2-chloroethyl)-3-(4-methoxyphenyl)propanamide;1-(2-chloropyrimidin-4-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;1-(4-chloropyrimidin-2-yl)-3-[(4-methoxyphenyl)methyl]imidazolidin-2-one;(4-methoxyphenyl)methanamine;1-[(4-methoxyphenyl)methyl]imidazolidin-2-one is sourced from PubChem (CID 162132979), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).